Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Total monthly reach
Estimated from 5 chart positions in 5 markets.
By chart position
- 🇪🇸ES · Medicine#4030K to 100K
- 🇳🇬NG · Medicine#2100K to 300K
- 🇸🇬SG · Medicine#159500 to 3K
- 🇹🇭TH · Medicine#194500 to 3K
- 🇦🇷AR · Medicine#194500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
66K to 205K🎙 ~2x weekly·597 episodes·Last published yesterday - Monthly Reach
Unique listeners across all episodes (30 days)
132K to 409K🇳🇬73%🇪🇸24%🇸🇬1%+2 more - Active Followers
Loyal subscribers who consistently listen
53K to 164K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
Better Drying? Longer Lasting? Second-Generation Anti-VEGF Therapies in Clinical Practice
Jun 23, 2026
Unknown duration
Shaping the Future of Precision Oncology: Biomarker-Driven Care for Tumor-Agnostic Therapies
Jun 17, 2026
Unknown duration
Navigating the Management of Alagille Syndrome Using Ileal Bile Acid Transporter (IBAT) Inhibitors
Jun 17, 2026
Unknown duration
Chronic Inflammatory Demyelinating Polyradiculoneuropathy Care Partnerships: Aligning Goals for Better Outcomes
Jun 5, 2026
Unknown duration
The Molecular Nuances of Hemostasis: Differentiating FVIII and Non-Factor Replacement
Jun 2, 2026
Unknown duration
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 6/23/26 | Better Drying? Longer Lasting? Second-Generation Anti-VEGF Therapies in Clinical Practice | Learn to optimize durability and drying with new second-generation anti-VEGF therapies. Credit available for this activity expires: 6/19/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/https://www.medscape.org/viewarticle/better-drying-longer-lasting-second-generation-anti-vegf-2026a1000k53?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 6/17/26 | Shaping the Future of Precision Oncology: Biomarker-Driven Care for Tumor-Agnostic Therapies | Do you know how tumor-agnostic therapies are helping to reshape cancer treatment pathways? Credit available for this activity expires: 6/16/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/shaping-future-precision-oncology-biomarker-driven-care-2026a1000jpk?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 6/17/26 | Navigating the Management of Alagille Syndrome Using Ileal Bile Acid Transporter (IBAT) Inhibitors | Which patients with Alagille syndrome benefit from IBAT inhibitors, and what should you watch for during therapy? Credit available for this activity expires: 6/16/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/navigating-management-alagille-syndrome-using-ileal-bile-2026a1000g3c?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 6/5/26 | Chronic Inflammatory Demyelinating Polyradiculoneuropathy Care Partnerships: Aligning Goals for Better Outcomes | How does it feel to live with CIDP? Bridge the gap between metrics and patient reality. Align goals and improve outcomes via shared decision-making. Credit available for this activity expires: 6/4/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/chronic-inflammatory-demyelinating-polyradiculoneuropathy-2026a1000g2n?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 6/2/26 | The Molecular Nuances of Hemostasis: Differentiating FVIII and Non-Factor Replacement | Do you know how the different therapies act in hemophilia A? Credit available for this activity expires: 05/29/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/molecular-nuances-hemostasis-differentiating-fviii-and-non-2026a1000hk2?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 6/1/26 | Depression and Neurological Diseases: What's the Link? | Can you untangle the threads linking depression and neurological disease to effectively treat your patients? Credit available for this activity expires: 06/01/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/depression-and-neurological-diseases-whats-link-2026a1000dco?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 5/21/26 | What Lies Beneath Generalized Myasthenia Gravis: Exploring Novel Mechanisms of Action of Emerging Therapies | What is lacking in the care of your patients with myasthenia gravis? Find out how novel pathology-targeting therapies can meet unmet needs. Credit available for this activity expires: 5/19/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/what-lies-beneath-generalized-myasthenia-gravis-exploring-2026a1000fuh?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 5/21/26 | Charting New Frontiers in Advanced Breast Cancer: Milestones, Missions, and Mastery | What do the latest clinical trial data tell us and how do they impact practice? Credit available for this activity expires: 5/20/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/charting-new-frontiers-advanced-breast-cancer-milestones-2026a1000fu7?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 5/18/26 | Beyond SGLT2: The Emerging Role of Dual SGLT1/2 Inhibition in Heart Failure | Discover how dual sodium-glucose cotransporter 1/2 (SGLT1/2) inhibition can improve outcomes for your patients across the heart failure (HF) spectrum. Credit available for this activity expires: 05/15/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/beyond-sglt2-emerging-role-dual-sglt1-2-inhibition-heart-2026a1000es7?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 5/14/26 | Addressing Unmet Needs in the Management of Sjögren's Disease: A Spotlight on Emerging Biologic Therapies | Keep up with the move toward targeted disease modifying therapies in Sjögren's disease. Credit available for this activity expires: 05/12/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/addressing-unmet-needs-management-sj%C3%B6grens-disease-2026a1000dvs?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 5/1/26 | Challenges and Opportunities in the Diagnostic Pathway for Biliary Atresia | Recognize biliary atresia (BA) signs early to stop pediatric liver transplant. Gain expert insights on screening, diagnosis, and urgent referral pathways. Credit available for this activity expires: 05/01/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/challenges-and-opportunities-diagnostic-pathway-biliary-2026a1000bpb?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 4/30/26 | Diabetic Macular Edema: Express Q&A on What's New | Improve real-world DME outcomes by mastering the interpretation of evolving biomarkers and the latest evidence on long-acting anti-VEGF therapies. Credit available for this activity expires: [04/28/27] Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/diabetic-macular-edema-express-q-whats-new-2026a1000czk?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 4/13/26 | The Science of SGLT1 and SGLT2: Unpacking Dual Inhibition for Heart Failure | Sodium-glucose cotransporter 2 (SGLT2) inhibitors transformed HF care. Meet SGLT1, a transporter that may unlock even greater CV protection. Credit available for this activity expires: 4/10/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/science-sglt1-and-sglt2-unpacking-dual-inhibition-heart-2026a1000axj?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 3/30/26 | Liver Fibrosis in Type 2 Diabetes and Obesity: A Case-Based Approach | Intervening early can stop metabolic dysfunction-associated steatohepatitis (MASH) progressing to fibrosis. Which of your patients with type 2 diabetes (T2D) or obesity need treatment, and what therapies are available? Credit available for this activity expires: 3/26/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/liver-fibrosis-type-2-diabetes-and-obesity-case-based-2026a10008y0?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 3/23/26 | Clinical Perspectives on the Use of PI3K/AKT Pathway Inhibitors in the Management of HR+/HER2− Metastatic Breast Cancer | Where do PI3K/AKT pathway inhibitors fit in the modern treatment landscape of breast cancer? Credit available for this activity expires: 3/19/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/clinical-perspectives-use-pi3k-akt-pathway-inhibitors-2026a100087h?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 3/18/26 | New Horizons in Uveitic Macular Edema | Do you know when to suspect edema in uveitis and how to manage it? Credit available for this activity expires: 3/18/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/new-horizons-uveitic-macular-edema-2026a10007ij?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 3/18/26 | Metabolic Crossroads: Navigating the Obesity–Liver Disease Axis | Do you know how to optimally identify, risk stratify, and treat your patients with obesity and MASLD or MASH? Credit available for this activity expires: 03/17/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/metabolic-crossroads-navigating-obesity-liver-disease-axis-2026a10007kf?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 3/11/26 | Beyond the Update in Advanced/Recurrent Endometrial Cancer: How Evidence Is Shaping New Guidelines | What clinical trials led to updates in the treatment strategies for advanced/recurrent endometrial cancer? Credit available for this activity expires: 3/9/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/beyond-update-advanced-recurrent-endometrial-cancer-how-2026a10006up?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 3/10/26 | Beyond PSMA: Preparing Your Practice for the Next Wave of Prostate Cancer Biomarkers | Are you up to speed on emerging biomarkers? Join our expert panel to learn more about their clinical relevance and testing best practices Credit available for this activity expires: 3/6/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/beyond-psma-preparing-your-practice-next-wave-prostate-2026a10006ql?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 3/5/26 | Avoiding Common Mistakes in Managing Focal Epilepsy | Do you know how many seizures is too many? Or what drugs to avoid in older epilepsy patients? Credit available for this activity expires: 3/3/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/avoiding-common-mistakes-managing-focal-epilepsy-2026a10004kv?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 2/27/26 | From Prescription to Practice in Respiratory Diseases: Overcoming Barriers to Inhaler Adherence and Compliance | Are you optimizing inhaler choice and technique to achieve better outcomes? Credit available for this activity expires: 2/27/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/prescription-practice-respiratory-diseases-overcoming-2026a100058h?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 2/27/26 | The CLL Consultation: Partnering With Patients for Person-Centred Care | Do you know how person-centred care can help address the challenges faced by chronic lymphocytic leukaemia (CLL) patients? Credit available for this activity expires: 02/26/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/cll-consultation-partnering-patients-person-centred-care-2026a10005ap?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 2/27/26 | Immunotherapy for Non-Muscle-Invasive Bladder Cancer: Expert Takeaways From the Latest Updates | Did you know that combining Bacillus Calmette-Guérin (BCG) with immunotherapy significantly improves outcomes in high-risk bladder cancer? Credit available for this activity expires: 2/24/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/immunotherapy-non-muscle-invasive-bladder-cancer-expert-2026a10005af?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 2/19/26 | Navigating the HER2 Spectrum in Breast Cancer: Evolving Diagnostic Paradigms for Clinical Excellence | Are you up to date on HER2 testing best practices? Join our expert panel and discover the critical updates that guide treatment selection. Credit available for this activity expires: 2/17/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/navigating-her2-spectrum-breast-cancer-evolving-diagnostic-2026a10004ea?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 2/6/26 | 2025 Winter Conference Update: Novel and Emerging Treatment Strategies for Breast Cancer | What do the latest data from the 2025 breast cancer Winter Conference tell us? Credit available for this activity expires: 02/02/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/winter-conference-update-novel-and-emerging-treatment-2026a100030r?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
Showing 25 of 606
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
6 placements across 5 markets.
Chart Positions
6 placements across 5 markets.